New Issue: Credit Suisse prices $1 million 12.75% autocallable yield notes tied to BioMarin

By Marisa Wong

Madison, Wis., June 5 – Credit Suisse AG, London Branch priced $1 million of 12.75% autocallable yield notes due June 10, 2016 linked to the common stock of BioMarin Pharmaceutical Inc., according to a 424B2 filing with the Securities and Exchange Commission.

Interest will be payable monthly.

The notes will be called at par if the stock closes at or above its initial share price on Dec. 3, Jan. 4, 2016, Feb. 3, 2016, March 3, 2016, April 4, 2016 or May 3, 2016.

The payout at maturity will be par unless the stock ever closes at or below its knock-in level, 55% of its initial share price, during the life of the notes and finishes below its initial share price, in which case investors will be fully exposed to any losses.

Morgan Stanley & Co. LLC is the distributor.

Issuer:	Credit Suisse AG, London Branch
Issue:	Autocallable yield notes
Underlying stock:	BioMarin Pharmaceutical Inc. (Symbol: BMRN)
Amount:	$1 million
Maturity:	June 10, 2016
Coupon:	12.75%, payable monthly
Price:	Par
Payout at maturity:	Par unless stock ever closes at or below knock-in level and finishes below initial price, in which case full exposure to any losses
Call:	At par if stock closes at or above initial share price on Dec. 3, Jan. 4, 2016, Feb. 3, 2016, March 3, 2016, April 4, 2016 or May 3, 2016
Initial price:	$124.01
Knock-in level:	$68.2055, 55% of initial level
Pricing date:	June 3
Settlement date:	June 10
Distributor:	Morgan Stanley & Co. LLC
Fees:	0.95%
Cusip:	22546VCL8

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.